AboutUs
News
Career
Donate
Contact

Medical Women's Health

The focus of this department is clinical and translational research specific to health issues important for the care of women. Currently, the department is working in conjuction with the Biomedical Laboratories for Integrative Cancer Research (BLICaR) at the College of Staten Island, City University of New York to develop new methods to improve cervical cancer screening.  A novel staining method for the diagnosis of cervical cancer and pre-cancerous lesions has been developed and has led to the filing of a patent with Staten Island University Hospital as the sponsoring institution. 

Division Director
Mario Castellanos, MD - Director of Clinical Research

  • Recent Grants:  
    • Empire Clinical Research Investigator Program 
      2009-2011  
      New York State Department of Health   
      "Abnormal Pap Smear Management" 
      PI: M. Castellanos, MD
      Award: $150,000
    • Empire Clinical Research Investigator Program 
      2008- 2009 
      New York State Department of Health 
      "Effects of pre-admission glucose control reflected by HgA1C levels on the morbidity and mortality of patients admitted to the ICU."   
      PI: M. Castellanos, MD
      Award: $75,000

  • International Patent Filing:
    • Title: A histochemical method to identify and predict disease progression of Human Papilloma Virus-infected lesions 
      Inventor: Mario Castellanos, MD 
      Application Assignment: SIUH and the Feinstein Institute for Medical Research International application No:PCT/US 09/49539 (WO/2010/003072) 
      Filing date: July 2, 2009 
      Publication: World Intellectual Property Organization:  http://www.wipo.int/pctdb/en/

  • Invited Presentations:
    • Endonuclease resistant DNA: A new marker to identify and predict disease progression of Human Papilloma Virus-infected lesions. - 26th International Papillomavirus Conference and Workshops, July 2010   MontrĂ©al, Canada

    • Virion associated DNA: A novel histochemical marker to identify women that are at risk to develop precancerous lesions of the cervix. - Society of Gynecologic Oncology 41   st   Annual Meeting March 2010,  San  Francisco ,  CA  .

    • Endonuclease Resistant DNA: A novel histochemical biomarker to distinguish low from high grade cervical intraepithelial neoplasia. - American Society of Colposcopy and Cervical Pathologists.  Las Vegas  Nevada  March 2010 

© 2014 Staten Island University Hospital. All Rights Reserved.

Privacy Policy | Sitemap | Notice of Privacy Practices | Compliance & Patient Privacy | Disclaimer